Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-05-14
1999-08-24
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 530350, 530300, 530324, 530325, 530326, 530327, 530328, 530329, C07K 1447, C07K 790, A61K 3804, A61K 3817
Patent
active
059424907
ABSTRACT:
A Bcl-2 associated protein (Bax) and uses thereof.
REFERENCES:
Yin et al., BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax, Nature 369:321-323 (1994).
Yin et al., BCL-2 functions by counteracting its dimerization partner, BAX, a death accelerator protein, Blood 82(10):441A, Abstract No. 1749 (Dec., 1993).
Hockenbery, D.M., et al., Bcl-2 Functions in an Antioxidant Pathway to Prevent Apoptosis, Cell (1993) 75, 241-251.
Oltvai, Z.N., et al., Bcl-2 Heterodimerizes in Vivo with a Conserved Homolog, Bax, That Accelerates Programmed Cell Death, Cell (1993) 74, 609-619.
Veis, D.J., et al., Bcl-2 Deficient Mice Demonstrate Fulminant Lymphoid Apoptosis, Polycystic Kidneys, and Hypopigmented Hair, Cell (1993) 75, 229-240.
Silverman, G.A., et al., Meiotic recombination between yeast artificial chromosomes yields a single clone containing the entire BCL2 protooncogene, Proc. Natl. Acad. Sci. USA, (1990) 87, 9913-9917.
Young, R.L., et al., A negative Regulatory Element in the bcl-2 5'-Untranslated Region Inhibits Expression from an Upstream Promotor, Mol. & Cell Biol., (1993) 13:6, 3686-3697.
Nunez, G., et al., Deregulated Bcl-2 Gene Expression Selectively Prolongs Survival of Growth Factor-Deprived Hemopoietic Cell Lines, J. Immun., (1990) 144:9, 3602-3610.
Sentman, C.L., Bcl-2 Inhibits Multiple Forms of Apoptosis but Not Negative Selection in Thymocytes, Cell, (1991) 67, 879-888.
Nunez, G., et al., Bcl-2 maintains B cell memory, Nature, (1991) 353, 71-73.
McDonnell, T.J., et al., Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18), Nature, (1991) 349, 254-256.
McDonnell, T.J., et al., Deregulated Bcl-2-Immunoglobulin Transgene Expands a Resting but Responsive Immunoglobulin M and D-Expressing B-Cell Population, Mol. & Cell Biol. (1990) 10:5, 1901-1907.
McDonnell, T.J., et al., Bcl-2-Immunoglobulin Transgenic Mice Demonstrate Extended B Cell Survival and Follicular Lymphoproliferation, Cell, (1989) 57, 79-88.
Zutter, M., et al., Immunolocalization of the Bcl-2 Protein Within Hematopoietic Neoplasms, Blood, (1991) 78:4, 1062-1068.
Hockenbery, D.M., BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death, Proc. Natl. Acad. Sci. USA, (1991) 88, 6961-6965.
Hockenbery, D.M., Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death, Nature (1990) 348, 334-336.
Korsmeyer, S.J. Bcl-2 Initiates a New Category of Oncogenes: Regulators of Cell Death, Blood, (1992) 80:4, 879-886.
Nakayama, K., Disappearance of the Lymphoid System in Bcl-2 Homozygous Mutant Chimeric Mice, Science, (1993) 261, 1584-1588.
Korsmeyer, S.J., Bcl-2: An Antidote to Programmed Cell Death, Cancer Surveys, (1992) 15, 105-118.
Korsmeyer, S.J., Bcl-2: A repressor of lymphocyte death, Immunol. Today (1992) 13:285-288.
McKearn et al., Enrichment of hematopoietic precursor cells and cloning of multipotential B-lymphocyte precursors, Proc. Nat. Acad. Sci., U.S.A., (1985) 82:7414-7418.
Lipford et al., Refinement of Lymphoma Cytogenetics by the Chromosome 18q21 Major Breakpoint Region, Blood (1987) 70:1816-1823.
Cleary et al., Cloning and Structural Analysis of cDNAs for bcl-2 and a Hybrid bcl-2/Immunoglobulin Transcript Resulting from the t(14;18)Translocation, Cell (1986) 47:19-28.
Kozopas et al., MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2, Proc. Nat. Acad. Sci., U.S.A., (1993) 90:3516-3520.
Bugaisky Gabriele E.
Washington University
Wax Robert A.
LandOfFree
Cell death regulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cell death regulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell death regulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-467069